Diabetes eye damage linked to higher dementia risk

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

New research shows that type 2 diabetes and worsening diabetic retinopathy could raise risk of dementia and cognitive decline.

It turns out our eyes might be trying to tell us something about the brain, and it’s more serious than just blurry vision. A recent study in the American Journal of Ophthalmology followed nearly 770,000 older adults and found that those with type 2 diabetes, particularly people with worsening diabetic retinopathy, faced a significantly higher risk of dementia [1].

Diabetic retinopathy happens when high blood sugar slowly damages the tiny blood vessels in the retina. But this damage isn’t confined to the eyes; it mirrors similar changes in the brain’s blood vessels. It’s like cracks in a glass window. The more the glass weakens, the more likely the entire window might shatter. For the brain, that “shattering” shows up as cognitive decline or vascular dementia.

The study found that people with the most severe eye disease had a 58% higher risk of developing any type of dementia and more than double the risk of vascular dementia compared with those without diabetes. Alzheimer’s risk, however, was mostly linked to having diabetes itself rather than the severity of eye disease.

With this, eye exams may also be about protecting your brain. Routine screenings could flag microvascular damage early, offering doctors a chance to intervene before cognitive problems arise. As Millen S. Khangura, the study lead, explained, the retina can act like a “window” into systemic health.

For many older adults, this perspective shifts how we think about longevity. Maintaining healthy vision may not just extend sight; it could extend mental sharpness, independence and quality of life well into later years. Early interventions truly give us tangible ways to keep our cognition, mobility and daily independence intact.

The story gets more hopeful with new medications like Mounjaro and Zepbound. These drugs, containing tirzepatide, were originally designed to help with weight management and blood sugar control. But recent research suggests they may also slow the progression of diabetic retinopathy, reducing the need for invasive treatments such as laser therapy or injections [2].

While medications are exciting, doctors caution that lifestyle changes remain a cornerstone of long-term health. Exercise, a balanced diet, quitting smoking and keeping blood sugar, blood pressure and cholesterol in check all contribute to stronger blood vessels throughout the body. Even modest, sustained weight loss can improve overall vascular health, benefiting both retinal and cognitive function.

Longevity.Technology: This reinforces the principle that true longevity is about strengthening the body’s interconnected systems. Maintaining vascular health through lifestyle choices doesn’t just protect the eyes or the brain; it builds resilience across multiple organs, extending both lifespan and healthspan. The habits you adopt today ripple into decades of sharper cognition, preserved vision and overall vitality.

The body is a connected system. Eye health, vascular health, and brain health aren’t isolated; they inform and influence one another. For older adults with diabetes, paying attention to vision changes is a window into cognitive resilience and the potential to live longer, healthier lives.

As medicine uncovers more of these early signals, the opportunity to intervene and preserve both sight and mind grows clearer. Protect your eyes, manage your diabetes and nurture the body as a whole because every small step today could mean sharper vision, a clearer mind and more years lived.

[1] https://pubmed.ncbi.nlm.nih.gov/41692179/ 
[2] https://www.aaojournal.org/article/S0161-6420(26)00019-9/abstract

Kyle Umipig

Kyle has nine years of editorial writing experience. They have been following the longevity sector since 2022, focusing on research, emerging tech, and the companies shaping the future of aging and age-related health.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Sava raises $36m as glucose sensor deal takes shape

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE